A breast cancer cell microarray (CMA) as a rapid method to characterize candidate biomarkers

References

• Shi S-R, Shi Y, Taylor CR. Antigen retrieval immunohistochemistry review and future prospects in research and diagnosis over two decades. J Histochem Cytochem 2011; 59:13-32; PMID:21339172; http://dx.doi.org/10.1369/jhc.2010.957191
   PubMed Web of Science ®Google Scholar
• Zhao L, Yang X, Khan A, Kandil D. Diagnostic role of immunohistochemistry in the evaluation of breast pathology specimens. Arch Pathol Lab Med 2013; 138:16-24; http://dx.doi.org/10.5858/arpa.2012-0440-RA
   Web of Science ®Google Scholar
• Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. The Lancet 1998; 351:1451-67; http://dx.doi.org/10.1016/S0140-6736(97)11423-4.
   PubMed Web of Science ®Google Scholar
• Tremolada L, Magni F, Valsecchi C, Sarto C, Mocarelli P, Perego R, Cordani N, Favini P, Galli Kienle M, Sanchez J-C, et al. Characterization of heat shock protein 27 phosphorylation sites in renal cell carcinoma. PROTEOMICS 2005; 5:788-95; PMID:15682460; http://dx.doi.org/10.1002/pmic.200401134
   PubMed Web of Science ®Google Scholar
• Kampf C, Andersson A-C, Wester K, Björling E, Uhlen M, Ponten F. Antibody-based tissue profiling as a tool for. Clin Proteomics 2004; 1:285-99; http://dx.doi.org/10.1385/CP:1:3-4:285
   Google Scholar
• Kim M-S, Kuppireddy SV, Sakamuri S, Singal M, Getnet D, Harsha HC, Goel R, Balakrishnan L, Jacob HKC, Kashyap MK, et al. Rapid characterization of candidate biomarkers for pancreatic cancer using cell microarrays (CMAs). J Proteome Res 2012; 11:5556-63; PMID:22985314; http://dx.doi.org/10.1021/pr300483r
   PubMed Web of Science ®Google Scholar
• Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe J-P, Tong F, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006; 10:515-27; PMID:17157791; http://dx.doi.org/10.1016/j.ccr.2006.10.008
   PubMed Web of Science ®Google Scholar
• Kao J, Salari K, Bocanegra M, Choi Y-L, Girard L, Gandhi J, Kwei KA, Hernandez-Boussard T, Wang P, Gazdar AF, et al. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS ONE 2009; 4:e6146; PMID:19582160; http://dx.doi.org/10.1371/journal.pone.0006146
   PubMed Web of Science ®Google Scholar
• Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235:177-82; PMID: 3798106; http://dx.doi.org/10.1126/science.3798106
   PubMed Web of Science ®Google Scholar
• Sjögren S, Inganäs M, Lindgren A, Holmberg L, Bergh J. Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers. J Clin Oncol 1998; 16:462-9; PMID:9469329
   PubMed Web of Science ®Google Scholar
• Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989; 244:707-12; PMID: 2470152; http://dx.doi.org/10.1126/science.2470152
   PubMed Web of Science ®Google Scholar
• Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001; 344:783-92; PMID:11248153; http://dx.doi.org/10.1056/NEJM200103153441101
   PubMed Web of Science ®Google Scholar
• Fox SB, Fawcett J, Jackson DG, Collins I, Gatter KC, Harris AL, Gearing A, Simmons DL. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 1994; 54:4539-6; PMID:7519124
   PubMed Web of Science ®Google Scholar
• Louderbough JMV, Schroeder JA. Understanding the dual nature of CD44 in breast cancer progression. Mol Cancer Res 2011; 9:1573-86; PMID:21970856; http://dx.doi.org/10.1158/1541-7786.MCR-11-0156
   PubMed Web of Science ®Google Scholar
• Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci 2003; 100:3983-8; PMID:12629218; http://dx.doi.org/10.1073/pnas.0530291100
   PubMed Web of Science ®Google Scholar
• Honeth G, Bendahl P-O, Ringnér M, Saal LH, Gruvberger-Saal SK, Lövgren K, Grabau D, Fernö M, Borg Å, Hegardt C. The CD44+/CD24- phenotype is enriched in basal-like breast tumors. Breast Cancer Res 2008; 10:R53; PMID:18559090
   PubMed Web of Science ®Google Scholar
• Yehiely F, Moyano JV, Evans JR, Nielsen TO, Cryns VL. Deconstructing the molecular portrait of basal-like breast cancer. Trends Mol Med 2006; 12:537-44; PMID:17011236; http://dx.doi.org/10.1016/j.molmed.2006.09.004
   PubMed Web of Science ®Google Scholar
• Osta WA, Chen Y, Mikhitarian K, Mitas M, Salem M, Hannun YA, Cole DJ, Gillanders WE. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 2004; 64:5818-24; PMID:15313925; http://dx.doi.org/10.1158/0008-5472.CAN-04-0754
   PubMed Web of Science ®Google Scholar
• Baeuerle PA, Gires O. EpCAM (CD326) finding its role in cancer. Br J Cancer 2007; 96:417-23; PMID: 17211480; http://dx.doi.org/10.1038/sj.bjc.6603494
   PubMed Web of Science ®Google Scholar
• Spizzo G, Went P, Dirnhofer S, Obrist P, Simon R, Spichtin H, Maurer R, Metzger U, von Castelberg B, Bart R, et al. High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer. Breast Cancer Res Treat 2004; 86:207-13; PMID: 15567937; http://dx.doi.org/10.1023/B:BREA.0000036787.59816.01
   PubMed Web of Science ®Google Scholar
• Momburg F, Moldenhauer G, Hämmerling GJ, Möller P. Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res 1987; 47:2883-91; PMID:3552208
   PubMed Web of Science ®Google Scholar
• Martowicz A, Spizzo G, Gastl G, Untergasser G. Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines. BMC Cancer 2012; 12:501; PMID:23110550; http://dx.doi.org/10.1186/1471-2407-12-501
   PubMed Web of Science ®Google Scholar
• Takeichi M. Morphogenetic roles of classic cadherins. Curr Opin Cell Biol 1995; 7:619-27; PMID:8573335; http://dx.doi.org/10.1016/0955-0674(95)80102-2
   PubMed Web of Science ®Google Scholar
• Bryant DM, Stow JL. The ins and outs of E-cadherin trafficking. Trends Cell Biol 2004; 14:427-34; PMID: 15308209; http://dx.doi.org/10.1016/j.tcb.2004.07.007
   PubMed Web of Science ®Google Scholar
• Canel M, Serrels A, Frame MC, Brunton VG. E-cadherin–integrin crosstalk in cancer invasion and metastasis. J Cell Sci 2013; 126:393-401; PMID:23525005; http://dx.doi.org/10.1242/jcs.100115
   PubMed Web of Science ®Google Scholar
• Graves JD, Krebs EG. Protein phosphorylation and signal transduction. Pharmacol Ther 1999; 82:111-21; PMID:10454190; http://dx.doi.org/10.1016/S0163-7258(98)00056-4
   PubMed Web of Science ®Google Scholar
• Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006; 127:635-48; PMID:17081983; http://dx.doi.org/10.1016/j.cell.2006.09.026
   PubMed Web of Science ®Google Scholar
• Hunter T. Tyrosine phosphorylation: thirty years and counting. Curr Opin Cell Biol 2009; 21:140-6; PMID: 19269802; http://dx.doi.org/10.1016/j.ceb.2009.01.028
   PubMed Web of Science ®Google Scholar
• Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature 2001; 411:355-65; PMID:11357143; http://dx.doi.org/10.1038/35077225
   PubMed Web of Science ®Google Scholar
• Krause DS, Van Etten RA. Tyrosine kinases as targets for cancer therapy. N Engl J Med 2005; 353:172-87; PMID: 16014887; http://dx.doi.org/10.1056/NEJMra044389
   PubMed Web of Science ®Google Scholar
• Albeck JG, Brugge JS. Uncovering a tumor suppressor for triple-negative breast cancers. Cell 2011; 144:638-40; PMID:21376226; http://dx.doi.org/10.1016/j.cell.2011.02.030
   PubMed Web of Science ®Google Scholar